Hosted on MSN21h
Sanofi is transferring its global expertise in insulin production to Saudi Arabia, aligning with Vision 2030 programAs Saudi Arabia moves toward healthcare self-sufficiency under Vision 2030, the localization of vital pharmaceutical manufacturing has become a critical priority. In a major step forward, Sanofi, ...
At the moment, most insulin dosing information is recorded ... A similar add-on approach is being taken by Sanofi for its SoloStar pens, via a partnership with Biocorp. Medtronic's injector ...
Hosted on MSN1mon
Glooko and Hedia launch joint diabetes management solutiona single add-on connected device developed for use with Sanofi’s SoloStar and DoubleStar insulin injection pens, into its platform with the aim to enhance support for healthcare professionals ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results